🔬 The Molecular Pathway of Vascular Constriction
How does a hormonal trigger (like Norepinephrine) physically shrink a blood vessel? This is the cascade from receptor to contraction.
Step 1: The Trigger
Bind: Norepinephrine (Alpha-1) or Angiotensin II (AT1) binds to the receptor on the smooth muscle cell.
Step 2: The Calcium Bomb
Gq Protein → PLC → IP3: This pathway releases calcium from the Sarcoplasmic Reticulum (SR) internal storage tank. Intracellular Calcium spikes.
Step 3: The Sensor
Calcium binds Calmodulin: The Ca²⁺-Calmodulin complex activates Myosin Light Chain Kinase (MLCK).
Step 4: The Power Stroke
Phosphorylation: MLCK uses ATP to add a phosphate to Myosin. Myosin binds to Actin and pulls, shortening the cell. The vessel constricts.
How Drugs Interrupt This Pathway
| Drug Class | Step Blocked | Mechanism |
|---|---|---|
| Alpha-1 Blockers | Step 1 | Block the Norepinephrine receptor. |
| ACE Inhibitors / ARBs | Step 1 | Block Angiotensin II production or receptor. |
| Calcium Channel Blockers (CCBs) | Step 2 | Block calcium entry through VGCC. |
| Nitrates / NO donors | Relaxation | Increase cGMP → dephosphorylate myosin (force relaxation). |
The Pathological Shift (Why it stays constricted)
- Loss of NO: Oxidative stress destroys Nitric Oxide, so the vessel loses its "off" switch.
- Rho-Kinase Overactivity: This enzyme blocks the relaxation pathway, making the vessel hyper-sensitive to calcium.
- Structural Remodeling: Smooth muscle hypertrophies and collagen scars the wall, physically locking the vessel in a narrowed state.